# Task E14: Lead Optimization Screening Assays for ADMET, Safety Profiling, Rodent Pharmacokinetics and MTD

> **NIH NIH N01** · EUROFINS PANLABS, INC. · 2024 · $85,320

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 11200837
- **Project number:** 272201800007I-0-759302400002-1
- **Recipient organization:** EUROFINS PANLABS, INC.
- **Principal Investigator:** JACOB BODE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $85,320
- **Award type:** —
- **Project period:** 2018-05-01 → 2025-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11200837

## Citation

> US National Institutes of Health, RePORTER application 11200837, Task E14: Lead Optimization Screening Assays for ADMET, Safety Profiling, Rodent Pharmacokinetics and MTD (272201800007I-0-759302400002-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11200837. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*